Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 13 of about 13 for Merck & Co, Inc
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 53.85 +0.15 (0.28%) 1.08B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 60.40 +0.65 (1.09%) 170.34B
Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 1.09 +0.01 (0.93%) 47.67M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Alkermes Plc NASDAQ ALKS 55.02 +0.01 (0.02%) 7.95B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Xenon Pharmaceuticals Inc NASDAQ XENE 13.20 +0.66 (5.26%) 177.81M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Nektar Therapeutics NASDAQ NKTR 16.67 -0.04 (-0.24%) 2.11B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 48.76 +1.31 (2.76%)
Amphastar Pharmaceuticals Inc NASDAQ AMPH 10.43 -0.18 (-1.70%) 473.72M
Amphastar Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and ...
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.858 +0.010 (1.18%)
ALKERMES PLC DL-,01 FRA 8AK 44.13 +0.21 (0.48%)
NEKTAR THERAPEUTICS FRA ITH 13.12 +0.07 (0.55%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.000
XENON PHARMACEUTICALS FRA XP0 0.000